Christopher Raffo, MD
Orthopaedic Surgery · Bethesda, MDNPI 1750398905
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 76.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $9,545 and has fallen 88.3% since, to $1,120 in 2025.
Across 56 payments — averaging $340.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$15K
- Supreme Orthopedic Systems, LLC$3K
- Arthrex$1K
- Stryker$293
- Miach Orthopaedics, Inc.$136
- Fidia Pharma USA Inc.$54
- plus $146 from 6 others
What the payments were for
- Speaking & faculty fees$11,36360%
- Travel & lodging$3,62919%
- Food & beverage$1,7219%
- Education$2,33412%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 27 | $14,572 |
| Supreme Orthopedic Systems, LLC | 6 | $2,652 |
| Arthrex | 5 | $1,193 |
| Stryker | 8 | $293 |
| Miach Orthopaedics, Inc. | 1 | $136 |
| Fidia Pharma USA Inc. | 3 | $54 |
| Zimmer Biomet | 1 | $45 |
| Johnson & Johnson | 1 | $26 |
| Bioventus LLC | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| ERMI LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Coblation Wands$2,225
- Dyonics Powermini/Powermax$2,225
- Regeneten$1,381
- Q-FIX Hip$1,306
- ACCUPASS DIRECT Crescent XL$1,169
- Bioraptor Knotless$1,169
- Q-FIX$1,169
- SPEEDLOCK HIP$1,169
- PROCISE Tonsil$1,129
- HEALICOIL PK Hip$1,129
- DERMAL WOUND$1,129
- Journey II$1,129
- EVOS$1,129
- Bioinductive Implant with Arthroscopic Delivery System - Medium$886
- Bone Anchors with Arthroscopic Delivery System$744
- REAL INTELLIGENCE$705
- MICRORAPTOR Knotless Shoulder$574
- Dyonics Platinum$144
- Endobutton$144
- FIRSTPASS MINI$144
How this compares
$19,046 in reported general payments places this provider in the 80th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 77 | $2,424 |
| Diclofenac Sodium | 33 | $385 |
| Methylprednisolone | 28 | $196 |
| Meloxicam | 14 | $43 |
| Cyclobenzaprine Hcl | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bethesda
- Hamid HassanzadehBethesda$1.1M
- Craig ForsthoefelBethesda$30K
- Colin NevinsBethesda$30K
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$7.6M
- Anand MurthiBaltimore$3.7M
- Timothy CoddTowson$3.6M
- Khaled KebaishBaltimore$3M
- Michael AinLutherville$1.6M
- Shawn StandardBaltimore$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.